IMG is announced as the new Channel Partner in Ukraine

In spring 2017, Illumina has signed a distribution agreement with life science reagents supplier Integrated Medical Group (IMG) to distribute the firm’s genomics research products in Ukraine.

Illumina has made its products available on the Ukrainian market for more than 5 years but the new distributorship allows researchers to order reagents from within the country and provides them with local customer care. IMG will distribute Illumina’s full range of reagents for genomics research, particularly, next-generation sequencing in Ukraine. From now on, researchers and practitioners can take advantage of direct sales and support from Illumina, bypassing third-country mediators. Thus the industry-acclaimed products and applications based on DNA sequencing have become more affordable to Ukrainian customers.